Evidence map›Paper›PMID 38391653›Full record

ArticleBioengineering (Basel, Switzerland)2024

Flávia Cristina Zanchetta, Pieter De Wever, Joseane Morari, Rita Caiado Gaspar, Thaís Paulino do Prado, Tess De Maeseneer, Ruth Cardinaels, Eliana Pereira Araújo, Maria Helena Melo Lima, Pedro Fardim

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Synthesis and Characterization of Ibuprofen-TiOBioengineering (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Flávia Cristina ZanchettaFaculty of Nursing, University of Campinas, Campinas 13083-887, Brazil.ORCID 0000-0002-5934-9683
Pieter De WeverDepartment of Chemical Engineering, University of Leuven KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0002-1172-6486
Joseane MorariLaboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, Campinas 13083-887, Brazil.
Rita Caiado GasparDepartment of Chemical Engineering, University of Leuven KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0002-7587-1949
Thaís Paulino do PradoFaculty of Nursing, University of Campinas, Campinas 13083-887, Brazil.ORCID 0000-0001-5740-8072
Tess De MaeseneerDepartment of Chemical Engineering, University of Leuven KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0001-7848-3514
Ruth CardinaelsDepartment of Chemical Engineering, University of Leuven KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0002-4191-6504
Eliana Pereira AraújoFaculty of Nursing, University of Campinas, Campinas 13083-887, Brazil.
Maria Helena Melo LimaFaculty of Nursing, University of Campinas, Campinas 13083-887, Brazil.
Pedro FardimDepartment of Chemical Engineering, University of Leuven KU Leuven, 3001 Leuven, Belgium.
KU Leuven · BEUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of chronic wounds is challenging, and the development of different formulations based on insulin has shown efficacy due to their ability to regulate oxidative stress and inflammatory reactions. The formulation of insulin with polysaccharides in biohybrid hydrogel systems has the advantage of synergistically combining the bioactivity of the protein with the biocompatibility and hydrogel properties of polysaccharides. In this study, a hydrogel formulation containing insulin, chitosan, and hydroxypropyl methyl cellulose (Chi/HPMC/Ins) was prepared and characterized by FTIR, thermogravimetric, and gel point analyses. The in vitro cell viability and cell migration potential of the Chi/HPMC/Ins hydrogel were evaluated in human keratinocyte cells (HaCat) by MTT and wound scratch assay. The hydrogel was applied to excisional full-thickness wounds in diabetic mice for twenty days for in vivo studies. Cell viability studies indicated no cytotoxicity of the Chi/HPMC/Ins hydrogel. Moreover, the Chi/HPMC/Ins hydrogel promoted faster gap closure in the scratch assay. In vivo, the wounds treated with the Chi/HPMC/Ins hydrogel resulted in faster wound closure, formation of a more organized granulation tissue, and hair follicle regeneration. These results suggest that Chi/HPMC/Ins hydrogels might promote wound healing in vitro and in vivo and could be a new potential dressing for wound healing.

Indexed as

biopolymershydrogelsinsulinpolysaccharideswound healing

Identifiers

PMID38391653
PMCPMC10886365
OpenAlexW4391692412

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.